Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Woodford reveals his shock-proof top 10

1 Comment
Woodford reveals his shock-proof top 10

Renowned fund manager Neil Woodford has unveiled the top 10 holdings in his new fund that he believes are built to last.

Woodford's top position in the fledgling CF Woodford Equity Income fund is AstraZeneca at 8.3%. The star manager publicly opposed Pfizer's takeover bid the company. It is followed by fellow pharma GlaxoSmithKline at 7.1% and British American Tobacco at over 6.2%.

The top 10 bears a perhaps unsurprising resemblance to the top 10 of his former fund, Invesco Perpetual Income, now run by Citywire AA-rated Mark Barnett, dominated by big pharma and tobacco. Other holdings that cross both top 10s are BT, Roche, Capita and Rolls-Royce.

Woodford's top 10 differs with the inclusion of Imperial Innovations and Reynolds American, however.

Woodford said the portfolio seeks to avoid sectors that he believes are vulnerable to a faltering global economy.

'There is significant emphasis in my new fund on the tobacco and pharmaceutical sectors. These two sectors are resilient to falling demand, have strong balance sheets and attractive valuations,' he added. 

Woodford's view on the global economy remains unchanged, he noted: 'The liquidity flows that have supported asset prices over the past five years are going into reverse, while growth in many parts of the world is being downgraded.

'The global economy and financial markets both face a tricky time over the next few years, but there are still many undervalued assets in equity markets and it is these opportunities that the fund is seeking to exploit.'

Comparing himself to a pilot, Woodford said:'We have taken off and we have already gained a lot of height, but we are not yet at cruising altitude. The portfolio will continue to evolve.'

The fund raised £1.6 billion in its offer period.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.

Related Fund Managers

Neil Woodford
Neil Woodford
14/83 in Equity - UK Equity Income (Performance over 3 years) Average Total Return: 58.97%
Mark Barnett
Mark Barnett
12/83 in Equity - UK Equity Income (Performance over 3 years) Average Total Return: 61.48%
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

This week Brewin Dolphin's head of research talks to Mike Riddell, fund manager at Allianz Global Investors, about the forces driving bonds markets in a tumultuous week for markets.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter